5-Aminolevulinate, sn-Glycero-3-phosphoethanolamine, and L-Tryptophan could not only induce hyperlipidemia but also cause adverse effects on liver function based on the positive relationship between these compounds and TG, MDA, ALT, and LDL-C (p < 0.05). The gene discussed is GPT; the disease is hyperlipidemia.